Last updated on August 2014

ENSURE-AF


Brief description of study

ENSURE-AF

Detailed Study Description

A Prospective, Randomized, Open-Label Blinded Endpont Evaluation (PROBE) Parallel Group Study Comparing Edoxaban (DU-176b) With Enoxaparin/Warfarin Followed by Warfarin Alone in subjects undergoing planned electrical Cardioversion of Nonvalvular Atrial Fibrillation

Clinical Study Identifier: TX138951

Contact Investigators or Research Sites near you

Start Over

Robin Buckner

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »